Drugs & 
Pill 
Interaction 
Side 
Conditions 
Treatment 
Compare 
My Med 
Discount 
FDA 
Price 
Phonetic 
Health Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
FDA Approves Otulfi (ustekinumab-aauz), a Biosimilar to Stelara
Fresenius Kabi, an operating company of Fresenius, specializing in biopharmaceuticals, clinical nutrition, medical technologies, and I.V. generic drugs...
FDA Approves Flyrcado (flurpiridaz F 18) Radioactive Diagnostic for Enhanced Diagnosis of Coronary Artery Disease
(BUSINESS WIRE) September 27, 2024 --GE HealthCare (Nasdaq: GEHC) today announced that the U.S. Food and Drug Administration (FDA) has granted approval...
FDA Approves Cobenfy (xanomeline and trospium chloride), a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults
(BUSINESS WIRE)--26 September 2024-- Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved Cobenfy...
Tagrisso approved in the US for patients with unresectable, Stage III EGFR-mutated lung cancer
26 September 2024--AstraZeneca’s Tagrisso (osimertinib) has been approved in the US for the treatment of adult patients with unresectable, Stage...
FDA Approves Aqneursa (levacetylleucine) for the Treatment of Niemann-Pick Disease Type C
AUSTIN, TX, September 25, 2024– IntraBio Inc., a leader in the discovery and development of innovative drugs for rare neurodegenerative diseases,...
Time-Restricted Eating Improves Glycemic Regulation in Metabolic Syndrome
Time-restricted eating (TRE), limiting dietary intake to eight to 10 hours without mandating calorie restriction, combined with standard-of-care (SOC)...
Implementation of Suicide Care in Primary Care Cuts Rate of Suicide Attempts
Implementation of population-based suicide care (SC) in primary care yields an increase in the rates of safety planning and a reduction in suicide attempts,...
Few With Abnormal Protein Dipstick Results Have Albuminuria Testing
Few patients with abnormal protein dipstick results have follow-up albuminuria quantification, according to a research letter published online Oct. 1 in...
FDA Approves Miplyffa for Treatment of Niemann-Pick Disease, Type C
The U.S. Food and Drug Administration has approved Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC). Miplyffa,...
Falling Linked to Raised Risk of Dementia in Older People
More than 14 million seniors a year take a tumble, and those falls can be life-changing. "The relationship between falls and dementia appears to...
Shorter Course of Breast Cancer Radiation Won't Affect Breast Reconstruction
A shorter course of post-mastectomy radiation doesn't jeopardize a patient's chances of successful breast reconstruction, a new study finds. About 40...
Cluster of 8 Possible Human Bird Flu Cases Now Reported in Missouri
In what could be the first cases of bird flu spreading between humans in the United States, a group of potential H5N1 infections in Missouri has now grown...
What Do Families Fight About Most? New Study Finds Out
In a world where families may be more apt to interact with technology than with one another, some things never change. Many still struggle to get along....
New research confirms link between perceived stress and psoriasis relapse
AMSTERDAM, Sept. 26, 2024. Psoriasis, a chronic skin condition affecting over 6 million people in Europe, is characterized by rapid skin cell production,...
DURECT Corporation Announces Phase 3 Registrational Trial Design for Larsucosterol in Alcohol-associated Hepatitis
CUPERTINO, Calif. , Sept. 25, 2024. DURECT Corporation, a late-stage biopharmaceutical company pioneering the development of epigenetic therapies to transform...
Know What 'Chroming' Is? TikTok Fad Could Harm Your Kids
Chroming, where toxic fumes from common household items are inhaled for a quick high, is on the rise among youth and TikTok may be to blame, new research...
FDA is Alerting Patients and Health Care Professionals About the Voluntary Withdrawal of Oxbryta from the Market Due to Safety Concerns
FDA is alerting patients, caregivers, and health care professionals that Oxbryta (voxelotor) is being voluntarily withdrawn from the market by the manufacturer...
Recently Added
Recently added consumer and prescribing information: Otulfi, Tecentriq Hybreza, Pavblu, Livdelzi, Yorvipath, Crexont, Lymphir, Epysqli, Pyzchiva, Ahzantive
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex Carenotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Otulfi Otulfi (ustekinumab-aauz) is a human interleukin-12 and -23 antagonist biosimilar to Stelara used for the treatment of plaque psoriasis...
- Flyrcado Flyrcado (flurpiridaz F 18) is a positron emission tomography (PET) myocardial perfusion imaging (MPI) agent used for the detection of...
- Cobenfy Cobenfy (xanomeline and trospium chloride) is a muscarinic agonist and muscarinic antagonist combination indicated for the treatment of...
Drugs in Development (Not yet approved)
- Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil tentatively approved for the treatment of pulmonary arterial...
Drug Information
Tools
- Interaction Checker
- Pill Identifier
- Symptom Checker
- Medication Record
- Mobile Apps
- Drug Imprint Codes
- Community Support
- Compare Drugs
News & Alerts
- Medical News
- Clinical Trial Results
- FDA Drug Alerts
- FDA Consumer Updates
- New FDA Approvals
- New Drug Applications
- Drug Shortages
- Video Center
- Popular Articles
Professionals
Top 100 Drugs
- Abilify
- Acetaminophen
- Adderall
- Alprazolam
- Ambien
- Amitriptyline
- Amlodipine
- Amoxicillin
- Ativan
- Atorvastatin
- Avastin
- Azithromycin
- Baclofen
- Benadryl
- Benzonatate
- Biktarvy
- Botox
- Buprenorphine
- Bupropion
- Buspirone
- Cephalexin
- Cetirizine
- Ciprofloxacin
- Citalopram
- Clindamycin
- Clonazepam
- Clonidine
- Cyclobenzaprine
- Cymbalta
- Dexamethasone
- Diazepam
- Diclofenac
- Doxycycline
- Duloxetine
- Dupixent
- Eliquis
- Entyvio
- Epclusa
- Ezetimibe
- Famotidine
- Farxiga
- Fluoxetine
- Furosemide
- Gabapentin
- Humira
- Hydrochlorothiazide
- Hydrocodone
- Hydroxyzine
- Ibuprofen
- Januvia
- Jardiance
- Keytruda
- Klonopin
- Levothyroxine
- Lexapro
- Lisinopril
- Loratadine
- Lorazepam
- Losartan
- Lyrica
- Meloxicam
- Metformin
- Methadone
- Methylprednisolone
- Methocarbamol
- Methotrexate
- Metoprolol
- Metronidazole
- Miralax
- Mirtazapine
- Montelukast
- Mounjaro
- Mucinex
- Naloxone
- Naltrexone
- Naproxen
- Nitrofurantoin
- Omeprazole
- Opdivo
- Ondansetron
- Otezla
- Oxycodone
- Ozempic
- Pantoprazole
- Paxlovid
- Penicillin
- Percocet
- Phentermine
- Plan B
- Praluent
- Prednisone
- Promethazine
- Propranolol
- Prozac
- Qulipta
- Repatha
- Restasis
- Rexulti
- Semaglutide
- Seroquel
- Sertraline
- Sildenafil
- Skyrizi
- Soma
- Spironolactone
- Stelara
- Sublocade
- Suboxone
- Taltz
- Tamsulosin
- Tizanidine
- Toradol
- Tramadol
- Trazodone
- Trintellix
- Tylenol
- Ubrelvy
- Valium
- Venlafaxine
- Verzenio
- Viagra
- Vraylar
- Vyvanse
- Wegovy
- Wellbutrin
- Xanax
- Xolair
- Zepbound
- Zofran
- Zoloft
- Zyrtec
